
Immunovant Stock Jumps as IMVT-1402 Trial Data Overshadows Wider Quarterly Loss
Immunovant Stock Jumps as IMVT-1402 Trial Data Overshadows Wider Quarterly LossImmunovant shares surged after investors focused on encouraging clinica...
Found 7,473 articles